Hoth Therapeutics earnings were -$7.5M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest HOTH earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$2.1M, up 30.6% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, HOTH reported annual earnings of -$7.8M, with -31% growth. The next HOTH earnings date is Mar 26, 2025.
What were Hoth Therapeutics's earnings last quarter?
On HOTH's earnings call on Invalid Date, Hoth Therapeutics (NASDAQ: HOTH) reported Q3 2024 earnings per share (EPS) of -$0.31, up 48.33% year over year. Total HOTH earnings for the quarter were -$2.13 million. In the same quarter last year, Hoth Therapeutics's earnings per share (EPS) was -$0.60.
The next HOTH earnings date is Invalid Date. Add HOTH to your watchlist to be reminded of Hoth Therapeutics's next earnings date.
What was HOTH's earnings growth in the past year?
As of Hoth Therapeutics's earnings date in Invalid Date, Hoth Therapeutics's earnings has grown year over year. HOTH earnings in the past year totalled -$7.51 million.
Is Hoth Therapeutics profitable or losing money?
As of the last Hoth Therapeutics earnings report, Hoth Therapeutics is currently losing money. Hoth Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$7.51 million, a 21.96% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.